Atopic Dermatitis

Higher Risk of Systemic, Psychiatric Conditions Found in Patients With Atopic Dermatitis

December 3rd 2021, 4:00pm

Article

A high comorbidity burden, including psychiatric, autoimmune, and systemic conditions, was found in US adult ambulatory populations with atopic dermatitis.

Dupilumab-Induced Ophthalmic Disease Common in Adults With Atopic Dermatitis

December 1st 2021, 6:00pm

Article

More than 1 in 3 patients with atopic dermatitis reported incidence of dupilumab-induced ocular surface disease (DIOSD), with asthma and family history of AD shown to further increase the risk of developing DIOSD.

Atopic Dermatitis Severity, Age at Diagnosis May Increase Risk of Ophthalmic Diseases

November 25th 2021, 4:00pm

Article

Moderate-to-severe disease, childhood onset, and systemic treatments were all associated with a greater risk of conjunctivitis in patients with atopic dermatitis, whereas use of soft and hard contact lenses were linked with risk of keratitis.

Machine Learning Approach Finds Several Severity-Associated Factors in Atopic Dermatitis

November 23rd 2021, 9:09pm

Article

Findings of a machine learning-based deep phenotyping approach found a myriad of factors associated with severe disease in atopic dermatitis, including age between 12 and 21 years or older than 52 years, lack of physical activity, and incidence of alopecia areata.

Dr Jonathan Silverberg on Potential Benefits, Challenges of JAK Inhibitor Use in Atopic Dermatitis

November 17th 2021, 8:51pm

Video

Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, explains efficacy and safety implications of JAK inhibitor use for atopic dermatitis.

Flu Vaccine May Decrease Asthma Risk in Patients With Atopic Dermatitis

November 10th 2021, 6:30pm

Article

Adults with atopic dermatitis were shown to be at lower risk of developing asthma if they were vaccinated against influenza, particularly those who adhered to yearly shots.

Dr Jonathan Silverberg Explains JAK/STAT Pathway Involvement in Atopic Dermatitis

November 9th 2021, 2:00pm

Video

Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, discusses the involvement of the JAK/STAT pathway in the pathogenesis of atopic dermatitis.

Children With Atopic Dermatitis More Prone to Depression, Internalizing Behaviors

November 4th 2021, 2:00pm

Article

Children with severe atopic dermatitis were shown to be at nearly 2-fold greater risk of both depression and internalizing behaviors, with mild disease also associated with internalizing behaviors in those as young as 4 years of age.

Prenatal Exposure to Metals May Increase Risk of Atopic Dermatitis in Children

November 1st 2021, 6:00pm

Article

Prenatal exposure to inorganic arsenic and coexposure to inorganic arsenic and cadmium was found to increase risk of atopic dermatitis by up to 2.42-fold in young Taiwanese children.

Ruxolitinib Cream Approved for Short-term Treatment of Atopic Dermatitis

September 22nd 2021, 9:50pm

Article

Ruxolitinib cream, to be sold under the name Opzelura, is the first topical Janus kinase inhibitor cream for the treatment of atopic dermatitis.